BioNTech SE (BNTX)
110.23
+1.43
(+1.31%)
USD |
NASDAQ |
Feb 27, 16:00
110.27
+0.04
(+0.04%)
After-Hours: 20:00
BioNTech Excess Tax Benefit from Stock Compensation (Quarterly)
Excess Tax Benefit from Stock Compensation (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks
| GSK Plc | -- |
| Merck & Co., Inc. | -- |
| Novavax, Inc. | -- |
| Pfizer Inc. | -- |
| Moderna, Inc. | -- |